GENE ONLINE|News &
Opinion
Blog

Deals
Licensing Multiple Sclerosis
US Court Rules Novartis Blockbuster Multiple Sclerosis Drug’s Patent Invalid
2022-06-22
Funding Pfizer
Valneva Receives Funding From Pfizer to Develop World’s Only Lyme Disease Vaccine
2022-06-21
IPO China
Shenzhen Joincare Plots $300 Million IPO On Swiss Exchange
2022-06-20
Funding NASH
Akero Receives Up To $125 Million To Continue Liver Disease Treatment Development
2022-06-17
Licensing Greater China
Quion Licenses Two Rare Skin Disease Candidates to Hong Kong WinHealth
2022-06-16
Licensing MorphoSys
MorphoSys Thins Pipeline For Potential $1 Billion Deal While Progressing Oncology Ambitions
2022-06-16
Policy Antibiotic Resistance
UK Launches World-First Program With Two Antimicrobial Drugs to Counter Superbugs
2022-06-16
Funding Series B Funding
Dren Bio Draws $65 Million, Aiming for Phase 1 of ADCC Lead
2022-06-15
Funding Series B Funding
Elektrofi Secures $40 Million in Series B Funding For Drug Delivery Development
2022-06-15
Licensing China
Organon Licenses Biosimilars From Shanghai’s Henlius For $103 Million
2022-06-14
Funding Series A Funding
Series A Funding Successfully Wraps Up for Two Up-and-Coming Biotechs
2022-06-10
Licensing CDMO
Novartis and Samsung Biologics Sign Low-Profile $81 Million Deal
2022-06-10
IPO Funding
Forbion Looks to Fund IPO Ambitious Companies With Its €470 Million Fund
2022-06-10
Funding Gene Therapy
Astellas Ups Production of Gene Therapies With New Carolina Plant
2022-06-09
Partnerships Hepatitis C
Gilead Sciences Works Alongside Westminster Drug Project To Eliminate Hepatitis C
2022-06-09
1 … 17 18 19 20 21 … 47
LATEST
Pfizer’s Q1 2024 Revenue Declines, Offset by Strong Performance of Non-COVID-19 Products
2024-05-03
Novo Nordisk Revises Outlook: Reports 24% Growth in Q1 2024 Sales, Reaching DKK 65.3 Billion
2024-05-03
UC Riverside Scientists Unveil RNA-based Vaccine Strategy, Potentially Avoiding Endless Booster Shots
2024-05-02
Lilly’s Q1 2024 Financial Report: Full-Year Revenue Outlook Raised by $2 Billion, with a 67% Net Income Increase
2024-05-02
Taiwan Breakthrough: Next-Generation Sequencing Now Covered in Health Insurance, Benefitting 20,000 Cancer Patients Annually
2024-05-02
CellTech Accelerator and Cyto-Facto Inc. Forge Strategic Partnership to Advance CGT Industry Growth
2024-04-29
Kaiser’s Data Breach: 13.4 Million Affected in Healthcare Conglomerates Privacy Crisis
2024-04-26
READ MORE
EVENT
SEE MORE
Newsletter

Subscribe to receive updates.

SIGN UP
Facebook
Youtube
Twitter
Linkedin
About
Explore
More
© 2024 GeneOnline
Privacy Policy | Terms of Service
Privacy Policy | Terms of Service
  • Subscribe to our newsletter and dive into the world of biopharma with us.
SIGN UP
x
Scroll to Top